Subscribe to Specialty Providers

Specialty Providers

Upstate Homecare bets on infusion

 - 
05/23/2017

CLINTON, N.Y. – At a time when other HME companies are downsizing operations or shuttering entirely, Upstate Homecare is looking to grow, thanks to a renewed focus on specialty infusion care in the upstate New York area.

Option Care achieves perfect URAC score

 - 
05/23/2017

BANNOCKBURN, Ill. ­– Option Care, a national home infusion provider, recently earned accreditation from URAC Specialty Pharmacy for its corporate offices and its three specialty pharmacy centers of excellence. 

Data on diabetes explodes in the cloud

 - 
05/23/2017

Patients with diabetes create a lot of data, whether its their blood glucose levels, A1c results, or medication adherence.

Ascensia, Dr. Oz team up to empower people with diabetes

 - 
05/12/2017

PARSIPPANY, N.J. – Dr. Mehmet Oz has given Ascensia Diabetes Care a big boost in its efforts to educate people about diabetes and help the nearly 30 million Americans with the disease better manage their condition.

Judge deals setback to Arriva Medical

 - 
05/02/2017

CORAL SPRINGS, Fla. – Arriva Medical on April 25 lost an appeal seeking to reinstate its Medicare billing privileges, according to news reports.

For financial health, don't neglect business side of operations

 - 
04/24/2017

By the time David Franklin is brought on as a consultant, the company in question is often in dire need of a turnaround, he says.

Infusion conference looks 'homeward'

 - 
04/24/2017

ORLANDO, Fla. – Health care is “going home” and the upcoming National Home Infusion Association’s annual conference aims to help attendees plan for that future, say organizers.

Arriva Medical in ‘midst’ of ALJ appeal

Acquisition by Abbott Laboratories moves forward
 - 
04/21/2017

CORAL SPRINGS, Fla. – Arriva Medical, a provider of diabetes testing supplies, remains confident that it will get its Medicare billing status reinstated.

Abbott Labs, Alere deal moves forward

 - 
04/18/2017

ABBOTT PARK, Ill., and WALTHAM, Mass. – Abbott Laboratories has agreed to buy Alere, but at a lower price than it previously offered.

Pages